Innate Pharma
IPH · Euronext Paris
Public Market Listing
IPHEuronext Paris
Live quotes, historical charts, and market capitalization for Innate Pharma are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(3 total)
3Total Assets
0Approved
1Phase 3 / Filed
2Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | NKG2AMonoclonal antibody | Non-Small Cell Lung Cancer | |
| Phase 2 | KIR3DL2Monoclonal antibody | Cutaneous T-Cell Lymphoma | |
| Phase 1 | Nectin-4Antibody–drug conjugate | Non-Small Cell Lung Cancer |
Upcoming events
No upcoming trial completions or earnings dates on record for this company's assets.
Financial reports
No financial reports recorded.